Announcement

New Products Launched!

Auralief Oral Strips BLOOM Arousal Gel    

Newsroom

Insights into LOVE

Welcome to our newsroom where we post news, events, and financial updates.

November 2, 2022

LOVE PHARMA INVESTEE, STARTON THERAPEUTICS, STRENGTHENS BOARD WITH NEW MEMBER (RE-RELEASE)

Please see the previously announced news from Starton Therapeutics Inc. VANCOUVER, BC, CANADA (November 2nd,  2022) – LOVE Pharma Co.

Read More

October 20, 2022

NALTREXONE DEMONSTRATES PROMISING LONG COVID APPLICATION

Naltrexone primarily used to treat alcohol and or opioid has now shown promise in treating Long COVID at low doses1

Read More

October 19, 2022

Love Pharma Closes Acquisition of Doc Hygiene

VANCOUVER, BC, CANADA (October 19th, 2022) – LOVE Pharma Co. (“LOVE” or the “Company”)(CSE: LUV) (FSE: G1Q0), is pleased to

Read More

October 13, 2022

LOVE PHARMA – JOHNS HOPKINS UNIVERSITY PSILOCYBIN TRIAL ADVANCES TOWARD LAUNCH IN 2022

Dr. Albert Garcia Romeu will serve as head researcher for the Love Pharma’s MicroDoz sponsored trial to be conducted at

Read More

October 11, 2022

LOVE PHARMA SIGNS LETTER OF INTENT TO ACQUIRE NALTREXONE THERAPEUTICS INC.

Love Pharma adding to its addiction treatment portfolio with transdermal IP acquisition for opioid antagonist drug Naltrexone Naltrexone primarily used

Read More

September 30, 2022

LOVE PHARMA SUBSIDIARY DOC HYGIENE DELIVERS SANITIZER PRODUCTS TO SUPPORT COMMUNITY NEEDS WITH OPERATION “CLEAN HANDS” and Closes Final Tranche of Financing

VANCOUVER, BC, CANADA (September 30th, 2022) – LOVE Pharma Inc. (“LOVE” or the “Company“) (CSE: LUV) (FSE: G1Q0) is pleased

Read More

September 21, 2022

LOVE PHARMA LAUNCHES PROPRIETARY E-COMMERCE PLATFORM FOR ONLINE SALES

LOVE’s online store launches with fully integrated e-commerce platform Consumers can now purchase the Company’s two proprietary branded products, BLOOM

Read More

September 7, 2022

Love Pharma Initiates First Steps Towards a Strategic Alliance with Starton Therapeutics with Investment in this Biotech Leader

Starton Therapeutics is a leading clinical stage Biotechnology Company based in New Jersey led by CEO and Chairman, Mr. Pedro

Read More

August 25, 2022

LOVE PHARMA DELIVERS LETTER TO SHAREHOLDERS

Love Pharma President, Mr. Zach Stadnyk, delivers comprehensive report on the Company’s holdings and growth strategy Building upon the Company’s

Read More

August 24, 2022

LOVE PHARMA INC. ANNOUNCES FIRST CLOSING OF FINANCING

VANCOUVER, BC, CANADA (August 24, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it

Read More
1 2 3